As of October 19, 2026, the trial titled "Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer" has an updated status. The trial, registered as NCT04787744, is listed as Phase II/III. Its current status is active, not recruiting. This study evaluates standard systemic therapy with or without PET-directed local therapy in oligometastatic prostate cancer. Triptorelin is an approved compound associated with this trial record. No results have been posted in connection with this status update. The trial status indicates that enrollment is closed but participants already enrolled continue to be followed or treated under the study protocol. No efficacy or safety outcomes are described in this update. Readers interested in triptorelin's approved uses and background can consult the compound overview for further context.
Triptorelin Trial NCT04787744 Now Active, Not Recruiting as of Oct 2026
See the full triptorelin overview
Source: https://clinicaltrials.gov/study/NCT04787744